Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apnimed granted stock options to purchase an aggregate 481,300 shares to 19 new non-executive employees under its 2026 Inducement Plan. The options carry a $22.54 exercise price, equal to the closing price on the October 1, 2026 grant date, with four-year vesting.
Key figures
- Exercise price
- 22.54
- Employees granted
- 19
- Options granted shares
- 481300
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.